Melperon 1 A Pharma (Melperone Hydrochloride)

Melperone works by blocking dopamine D2 receptors in key brain pathways. This antagonism reduces excessive dopamine signalling that underlies the positive symptoms of psychosis, such as hallucinations and delusional thinking.

The appropriate dose of melperone is determined by the prescribing clinician based on the individual’s condition, response, and tolerability. Dosage may be adjusted during treatment to achieve optimal therapeutic effect.

Safety data for melperone in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Clinicians should weigh potential benefits against risks and consider alternative therapies when possible.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and required import documentation.

Melperone shares the dopamine D2 antagonism common to typical antipsychotics but may have a slightly different side‑effect profile, with lower rates of extrapyramidal symptoms reported in some studies. Choice of agent depends on individual patient factors and clinician judgment.

Melperon 1 A Pharma should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight to maintain stability.

The product is supplied as oral tablets and is taken by mouth with or without food, as directed by the prescriber. Swallow the tablet whole; do not crush or chew unless specifically instructed.

Serious adverse events include neuroleptic malignant syndrome, tardive dyskinesia, severe hypotension, seizures, and agranulocytosis. Patients should be monitored closely for any signs of these conditions, and treatment should be discontinued if they occur.

Melperone is contraindicated in patients with known hypersensitivity to melperone or any component of the formulation. Caution is advised in individuals with severe cardiovascular disease, uncontrolled hypertension, or a history of neuroleptic malignant syndrome.